Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Diagnostic Suspicion of Primitive Syndrome Sjögren's : Brest Cohort (DIApSS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03681964
Recruitment Status : Recruiting
First Posted : September 24, 2018
Last Update Posted : September 24, 2018
Sponsor:
Information provided by (Responsible Party):
University Hospital, Brest

Brief Summary:
This study aims to evaluate the diagnosis performance of several item used for the classification, the diagnosis and the prognostic of pSS (primary Sjogren syndrome)

Condition or disease
Primary Sjögren's Syndrome (pSS)

Layout table for study information
Study Type : Observational
Estimated Enrollment : 100 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Diagnostic Suspicion of Primitive Syndrome Sjögren's : Brest Cohort
Actual Study Start Date : September 28, 2015
Estimated Primary Completion Date : September 28, 2020
Estimated Study Completion Date : September 28, 2030

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. classification criteria [ Time Frame: Inclusion (Day 0) ]
    classification criteria at inclusion of patients with suspected primary Sjögren's syndrome (pSS) underwent with standardised evaluation



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients with suspected pSS underwent a standardised evaluation
Criteria

Inclusion Criteria:

  • Patients with suspected pSS underwent a standardised evaluation

Exclusion Criteria:

  • Opposition of patient

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03681964


Contacts
Layout table for location contacts
Contact: Valerie Devauchelle, MD,PhD 33 (0) 2 98 34 72 64 valerie.devauchelle-pensec@chu-brest.fr

Locations
Layout table for location information
France
CHRU de Brest Recruiting
Brest, France, 29609
Contact: Valerie Devauchelle         
Sponsors and Collaborators
University Hospital, Brest
Investigators
Layout table for investigator information
Study Director: Valerie Devauchelle CHRU de Brest

Layout table for additonal information
Responsible Party: University Hospital, Brest
ClinicalTrials.gov Identifier: NCT03681964     History of Changes
Other Study ID Numbers: DIApSS
First Posted: September 24, 2018    Key Record Dates
Last Update Posted: September 24, 2018
Last Verified: July 2018

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Xerostomia
Mouth Diseases
Dry Eye Syndromes
Sjogren's Syndrome
Syndrome
Disease
Pathologic Processes
Arthritis, Rheumatoid
Arthritis
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Salivary Gland Diseases
Stomatognathic Diseases
Lacrimal Apparatus Diseases
Eye Diseases
Connective Tissue Diseases
Autoimmune Diseases
Immune System Diseases